Hotchkis & Wiley Capital Management’s Taro Pharmaceutical Industries Ltd. TARO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2023
Q3
Sell
-223,542
Closed -$8.48M 542
2023
Q2
$8.48M Sell
223,542
-60,540
-21% -$2.3M 0.03% 224
2023
Q1
$6.91M Buy
284,082
+4,700
+2% +$114K 0.03% 280
2022
Q4
$8.11M Buy
279,382
+40,870
+17% +$1.19M 0.03% 213
2022
Q3
$7.15M Buy
238,512
+18,020
+8% +$540K 0.03% 208
2022
Q2
$7.97M Buy
220,492
+28,672
+15% +$1.04M 0.03% 218
2022
Q1
$8.3M Buy
191,820
+34,795
+22% +$1.51M 0.03% 229
2021
Q4
$7.87M Buy
157,025
+21,670
+16% +$1.09M 0.02% 232
2021
Q3
$8.61M Buy
135,355
+7,470
+6% +$475K 0.03% 190
2021
Q2
$9.2M Buy
127,885
+18,340
+17% +$1.32M 0.03% 193
2021
Q1
$8.08M Buy
109,545
+8,555
+8% +$631K 0.02% 210
2020
Q4
$7.42M Buy
100,990
+16,790
+20% +$1.23M 0.03% 146
2020
Q3
$4.62M Buy
84,200
+16,950
+25% +$930K 0.02% 205
2020
Q2
$4.47M Sell
67,250
-4,270
-6% -$284K 0.02% 213
2020
Q1
$4.38M Sell
71,520
-4,690
-6% -$287K 0.02% 166
2019
Q4
$6.7M Buy
76,210
+9,210
+14% +$810K 0.02% 219
2019
Q3
$5.06M Buy
67,000
+3,050
+5% +$230K 0.02% 219
2019
Q2
$5.46M Buy
63,950
+6,620
+12% +$566K 0.02% 215
2019
Q1
$6.2M Buy
+57,330
New +$6.2M 0.02% 140
2016
Q3
Sell
-151,330
Closed -$22M 188
2016
Q2
$22M Buy
151,330
+2,347
+2% +$342K 0.09% 119
2016
Q1
$21.3M Buy
148,983
+12,250
+9% +$1.75M 0.09% 118
2015
Q4
$21.1M Buy
136,733
+5,809
+4% +$898K 0.09% 130
2015
Q3
$18.7M Sell
130,924
-8,020
-6% -$1.15M 0.07% 135
2015
Q2
$20M Sell
138,944
-68,214
-33% -$9.8M 0.07% 145
2015
Q1
$29.2M Sell
207,158
-4,341
-2% -$612K 0.1% 137
2014
Q4
$31.3M Sell
211,499
-63,565
-23% -$9.42M 0.11% 135
2014
Q3
$42.3M Sell
275,064
-235,888
-46% -$36.3M 0.15% 110
2014
Q2
$71.7M Buy
510,952
+55,700
+12% +$7.81M 0.25% 89
2014
Q1
$50.5M Sell
455,252
-74,684
-14% -$8.29M 0.19% 100
2013
Q4
$52.4M Buy
529,936
+91,261
+21% +$9.03M 0.22% 88
2013
Q3
$33.3M Buy
+438,675
New +$33.3M 0.15% 102